Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 May;4(3):241–246. doi: 10.1128/cdli.4.3.241-246.1997

Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases.

P P Sfikakis 1, G C Tsokos 1
PMCID: PMC170511  PMID: 9144356

Full Text

The Full Text of this article is available as a PDF (110.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki S., Imai K., Yachi A. Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scand J Immunol. 1993 Nov;38(5):485–490. doi: 10.1111/j.1365-3083.1993.tb02592.x. [DOI] [PubMed] [Google Scholar]
  2. Aydintuğ A. O., Tokgöz G., Ozoran K., Düzgün N., Gürler A., Tutkak H. Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease. Rheumatol Int. 1995;15(2):75–78. doi: 10.1007/BF00262712. [DOI] [PubMed] [Google Scholar]
  3. Becker J. C., Termeer C., Schmidt R. E., Bröcker E. B. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol. 1993 Dec 15;151(12):7224–7232. [PubMed] [Google Scholar]
  4. Belmont H. M., Buyon J., Giorno R., Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum. 1994 Mar;37(3):376–383. doi: 10.1002/art.1780370311. [DOI] [PubMed] [Google Scholar]
  5. Blann A. D., Daly R. J., Amiral J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol. 1996 Feb;92(2):498–500. doi: 10.1046/j.1365-2141.1996.d01-1486.x. [DOI] [PubMed] [Google Scholar]
  6. Blann A. D., McCollum C. N., Steiner M., Jayson M. I. Circulating adhesion molecules in inflammatory and atherosclerotic vascular disease. Immunol Today. 1995 May;16(5):251–252. doi: 10.1016/0167-5699(95)80169-3. [DOI] [PubMed] [Google Scholar]
  7. Bruijn J. A., Dinklo N. J. Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease. Lab Invest. 1993 Sep;69(3):329–335. [PubMed] [Google Scholar]
  8. Carson C. W., Beall L. D., Hunder G. G., Johnson C. M., Newman W. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J Rheumatol. 1993 May;20(5):809–814. [PubMed] [Google Scholar]
  9. Chapman P. T., Jamar F., Keelan E. T., Peters A. M., Haskard D. O. Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum. 1996 Aug;39(8):1371–1375. doi: 10.1002/art.1780390815. [DOI] [PubMed] [Google Scholar]
  10. Claman H. N., Giorno R. C., Seibold J. R. Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin". Arthritis Rheum. 1991 Dec;34(12):1495–1501. doi: 10.1002/art.1780341204. [DOI] [PubMed] [Google Scholar]
  11. Cush J. J., Rothlein R., Lindsley H. B., Mainolfi E. A., Lipsky P. E. Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum. 1993 Aug;36(8):1098–1102. doi: 10.1002/art.1780360810. [DOI] [PubMed] [Google Scholar]
  12. Denton C. P., Bickerstaff M. C., Shiwen X., Carulli M. T., Haskard D. O., Dubois R. M., Black C. M. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol. 1995 Nov;34(11):1048–1054. doi: 10.1093/rheumatology/34.11.1048. [DOI] [PubMed] [Google Scholar]
  13. Etzioni A. Adhesion molecules in host defense. Clin Diagn Lab Immunol. 1994 Jan;1(1):1–4. doi: 10.1128/cdli.1.1.1-4.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Furukawa S., Imai K., Matsubara T., Yone K., Yachi A., Okumura K., Yabuta K. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum. 1992 Jun;35(6):672–677. doi: 10.1002/art.1780350611. [DOI] [PubMed] [Google Scholar]
  15. Gearing A. J., Newman W. Circulating adhesion molecules in disease. Immunol Today. 1993 Oct;14(10):506–512. doi: 10.1016/0167-5699(93)90267-O. [DOI] [PubMed] [Google Scholar]
  16. Gruschwitz M. S., Hornstein O. P., von Den Driesch P. Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum. 1995 Feb;38(2):184–189. doi: 10.1002/art.1780380206. [DOI] [PubMed] [Google Scholar]
  17. Hebbar M., Lassalle P., Janin A., Vanhée D., Bisiau S., Hatron P. Y., Tonnel A. B., Gosselin B. E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Role of resident mast cell-derived tumor necrosis factor alpha. Arthritis Rheum. 1995 Mar;38(3):406–412. doi: 10.1002/art.1780380318. [DOI] [PubMed] [Google Scholar]
  18. Hoffmann J. C., Räuker H. J., Krüger H., Bayer B., Zeidler H. Decreased levels of a soluble form of the human adhesion receptor CD58 (LFA-3) in sera and synovial fluids of patients with rheumatoid arthritis. Clin Exp Rheumatol. 1996 Jan-Feb;14(1):23–29. [PubMed] [Google Scholar]
  19. Hosaka S., Shah M. R., Pope R. M., Koch A. E. Soluble forms of P-selectin and intercellular adhesion molecule-3 in synovial fluids. Clin Immunol Immunopathol. 1996 Mar;78(3):276–282. doi: 10.1006/clin.1996.0039. [DOI] [PubMed] [Google Scholar]
  20. Humbría A., Díaz-González F., Campanero M. R., Arroyo A. G., Laffón A., González-Amaro R., Sánchez-Madrid F. Expression of L-selectin, CD43, and CD44 in synovial fluid neutrophils from patients with inflammatory joint diseases. Evidence for a soluble form of L-selectin in synovial fluid. Arthritis Rheum. 1994 Mar;37(3):342–348. doi: 10.1002/art.1780370307. [DOI] [PubMed] [Google Scholar]
  21. Inuzuka H., Seita T., Okamoto K., Iida K., Ogawa Y., Iwasa S. A sensitive ELISA for the characterization of two forms of circulating intercellular adhesion molecule-1 in human plasma. Biol Pharm Bull. 1995 Aug;18(8):1036–1040. doi: 10.1248/bpb.18.1036. [DOI] [PubMed] [Google Scholar]
  22. Janssen B. A., Luqmani R. A., Gordon C., Hemingway I. H., Bacon P. A., Gearing A. J., Emery P. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol. 1994 Dec;33(12):1112–1116. doi: 10.1093/rheumatology/33.12.1112. [DOI] [PubMed] [Google Scholar]
  23. Kiener H., Graninger W., Machold K., Aringer M., Graninger W. B. Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Exp Rheumatol. 1994 Sep-Oct;12(5):483–487. [PubMed] [Google Scholar]
  24. Kitani A., Nakashima N., Matsuda T., Xu B., Yu S., Nakamura T., Matsuyama T. T cells bound by vascular cell adhesion molecule-1/CD106 in synovial fluid in rheumatoid arthritis: inhibitory role of soluble vascular cell adhesion molecule-1 in T cell activation. J Immunol. 1996 Mar 15;156(6):2300–2308. [PubMed] [Google Scholar]
  25. Kling E., Bieg S., Boehme M., Scherbaum W. A. Circulating intercellular adhesion molecule 1 as a new activity marker in patients with systemic lupus erythematosus. Clin Investig. 1993 Apr;71(4):299–304. doi: 10.1007/BF00184731. [DOI] [PubMed] [Google Scholar]
  26. Koch A. E., Shah M. R., Harlow L. A., Lovis R. M., Pope R. M. Soluble intercellular adhesion molecule-1 in arthritis. Clin Immunol Immunopathol. 1994 May;71(2):208–215. doi: 10.1006/clin.1994.1074. [DOI] [PubMed] [Google Scholar]
  27. Koch A. E., Turkiewicz W., Harlow L. A., Pope R. M. Soluble E-selectin in arthritis. Clin Immunol Immunopathol. 1993 Oct;69(1):29–35. doi: 10.1006/clin.1993.1146. [DOI] [PubMed] [Google Scholar]
  28. Lhotta K., Neumayer H. P., Joannidis M., Geissler D., König P. Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis. Clin Sci (Lond) 1991 Oct;81(4):477–481. doi: 10.1042/cs0810477. [DOI] [PubMed] [Google Scholar]
  29. Machold K. P., Kiener H. P., Graninger W., Graninger W. B. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol. 1993 Jul;68(1):74–78. doi: 10.1006/clin.1993.1098. [DOI] [PubMed] [Google Scholar]
  30. Mason J. C., Kapahi P., Haskard D. O. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum. 1993 Apr;36(4):519–527. doi: 10.1002/art.1780360412. [DOI] [PubMed] [Google Scholar]
  31. Meager A., Bird C., Mire-Sluis A. Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors. J Immunol Methods. 1996 May 27;191(2):97–112. doi: 10.1016/0022-1759(96)00005-1. [DOI] [PubMed] [Google Scholar]
  32. Nash M. C., Shah V., Dillon M. J. Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin Exp Immunol. 1995 Jul;101(1):13–17. doi: 10.1111/j.1365-2249.1995.tb02270.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nash M. C., Wade A. M., Shah V., Dillon M. J. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age. Clin Exp Immunol. 1996 Jan;103(1):167–170. doi: 10.1046/j.1365-2249.1996.925616.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pino-Otín M. R., Viñas O., de la Fuente M. A., Juan M., Font J., Torradeflot M., Pallarés L., Lozano F., Alberola-Ila J., Martorell J. Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of systemic lupus erythematosus patients. J Immunol. 1995 Mar 15;154(6):3015–3024. [PubMed] [Google Scholar]
  35. Sfikakis P. P., Charalambopoulos D., Vayiopoulos G., Oglesby R., Sfikakis P., Tsokos G. C. Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus. Clin Exp Rheumatol. 1994 Jan-Feb;12(1):5–9. [PubMed] [Google Scholar]
  36. Sfikakis P. P., Tesar J., Baraf H., Lipnick R., Klipple G., Tsokos G. C. Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Immunol Immunopathol. 1993 Jul;68(1):88–92. doi: 10.1006/clin.1993.1100. [DOI] [PubMed] [Google Scholar]
  37. Sfikakis P. P., Tesar J., Theocharis S., Klipple G. L., Tsokos G. C. Increased frequency of in vivo hprt gene-mutated T cells in the peripheral blood of patients with systemic sclerosis. Ann Rheum Dis. 1994 Feb;53(2):122–127. doi: 10.1136/ard.53.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sfikakis P. P., Tsokos G. C. Increased levels of intercellular adhesion molecule 1 in patients with systemic lupus erythematosus: comment on the article by Mason et al. Arthritis Rheum. 1994 Feb;37(2):300–301. doi: 10.1002/art.1780370221. [DOI] [PubMed] [Google Scholar]
  39. Sfikakis P. P., Tsokos G. C. Lymphocyte adhesion molecules in autoimmune rheumatic diseases: basic issues and clinical expectations. Clin Exp Rheumatol. 1995 Nov-Dec;13(6):763–777. [PubMed] [Google Scholar]
  40. Shi-Wen X., Panesar M., Vancheeswaran R., Mason J., Haskard D., Black C., Olsen I., Abraham D. Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis factor alpha, and estrogen. Arthritis Rheum. 1994 Nov;37(11):1689–1697. doi: 10.1002/art.1780371119. [DOI] [PubMed] [Google Scholar]
  41. Sipsas N., Sfikakis P. P., Sfikakis P., Choremi H., Kordossis T. Serum concentrations of soluble intercellular adhesion molecule-1 and progress towards disease in patients infected with HIV. J Infect. 1994 Nov;29(3):271–282. doi: 10.1016/s0163-4453(94)91151-7. [DOI] [PubMed] [Google Scholar]
  42. Wang C. R., Liu M. F., Tsai R. T., Chuang C. Y., Chen C. Y. Circulating intercellular adhesion molecules-1 and autoantibodies including anti-endothelial cell, anti-cardiolipin, and anti-neutrophil cytoplasma antibodies in patients with vasculitis. Clin Rheumatol. 1993 Sep;12(3):375–380. doi: 10.1007/BF02231583. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES